Literature DB >> 27654009

Ferumoxytol negatively enhances T2 -weighted MRI of pedal osteomyelitis in vivo.

Alex Neuwelt1, Jens Langsjoen1, Thomas Byrd2, Stephen Eberhardt3, Gary Mlady3, Justin Baca4, Therese Bocklage5, Cathleen Martinez5, Jonathan Orner2, Marisa Rivera2, Laurel O Sillerud6.   

Abstract

Entities:  

Keywords:  Ferumoxytol; osteomyelitis; superparamagnetic iron oxide nanoparticle

Mesh：

Substances：

Year:  2016        PMID： 27654009      PMCID： PMC5352518          DOI： 10.1002/jmri.25437

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN： 1053-1807            Impact factor:   4.813


× No keyword cloud information.
  7 in total

1.  Incidence of nephrogenic systemic fibrosis after adoption of restrictive gadolinium-based contrast agent guidelines.

Authors:  Yingbing Wang; Tarik K Alkasab; Ozden Narin; Rosalynn M Nazarian; Rathachai Kaewlai; Jonathan Kay; Hani H Abujudeh
Journal:  Radiology       Date:  2011-05-17       Impact factor: 11.105

Review 2.  MR imaging of the diabetic foot: diagnostic challenges.

Authors:  Deep S Chatha; Patricia M Cunningham; Mark E Schweitzer
Journal:  Radiol Clin North Am       Date:  2005-07       Impact factor: 2.303

3.  Cellular magnetic resonance imaging for the differentiation of infectious and degenerative vertebral disorders: preliminary results.

Authors:  Guillaume Bierry; François Jehl; Nathalie Holl; Jean Sibilia; Sébastien Froelich; Pierre Froehlig; Jean-Louis Dietemann; Stéphane Kremer
Journal:  J Magn Reson Imaging       Date:  2009-10       Impact factor: 4.813

4.  Diagnostic accuracy of the physical examination and imaging tests for osteomyelitis underlying diabetic foot ulcers: meta-analysis.

Authors:  Marie T Dinh; Cybele L Abad; Nasia Safdar
Journal:  Clin Infect Dis       Date:  2008-08-15       Impact factor: 9.079

5.  Diabetic foot infections.

Authors:  Fassil W Gemechu; Fnu Seemant; Catherine A Curley
Journal:  Am Fam Physician       Date:  2013-08-01       Impact factor: 3.292

6.  ACR Appropriateness Criteria on suspected osteomyelitis in patients with diabetes mellitus.

Authors:  Mark E Schweitzer; Richard H Daffner; Barbara N Weissman; D Lee Bennett; Judy S Blebea; Jon A Jacobson; William B Morrison; Charles S Resnik; Catherine C Roberts; David A Rubin; Leanne L Seeger; Mihra Taljanovic; James N Wise; William K Payne
Journal:  J Am Coll Radiol       Date:  2008-08       Impact factor: 5.532

7.  Macrophage imaging by USPIO-enhanced MR for the differentiation of infectious osteomyelitis and aseptic vertebral inflammation.

Authors:  Guillaume Bierry; François Jehl; Nelly Boehm; Philippe Robert; Jean-Louis Dietemann; Stéphane Kremer
Journal:  Eur Radiol       Date:  2009-02-06       Impact factor: 5.315
  7 in total
  3 in total

Review 1.  Current and potential imaging applications of ferumoxytol for magnetic resonance imaging.

Authors:  Gerda B Toth; Csanad G Varallyay; Andrea Horvath; Mustafa R Bashir; Peter L Choyke; Heike E Daldrup-Link; Edit Dosa; John Paul Finn; Seymur Gahramanov; Mukesh Harisinghani; Iain Macdougall; Alexander Neuwelt; Shreyas S Vasanawala; Prakash Ambady; Ramon Barajas; Justin S Cetas; Jeremy Ciporen; Thomas J DeLoughery; Nancy D Doolittle; Rongwei Fu; John Grinstead; Alexander R Guimaraes; Bronwyn E Hamilton; Xin Li; Heather L McConnell; Leslie L Muldoon; Gary Nesbit; Joao P Netto; David Petterson; William D Rooney; Daniel Schwartz; Laszlo Szidonya; Edward A Neuwelt
Journal:  Kidney Int       Date:  2017-04-20       Impact factor: 10.612

2.  Longitudinal monitoring of microglial/macrophage activation in ischemic rat brain using Iba-1-specific nanoparticle-enhanced magnetic resonance imaging.

Authors:  Laurel O Sillerud; Yirong Yang; Lisa Y Yang; Kelsey B Duval; Jeffrey Thompson; Yi Yang
Journal:  J Cereb Blood Flow Metab       Date:  2020-09-22       Impact factor: 6.200

3.  Quantitative [Fe]MRI determination of the dynamics of PSMA-targeted SPIONs discriminates among prostate tumor xenografts based on their PSMA expression.

Authors:  Laurel O Sillerud
Journal:  J Magn Reson Imaging       Date:  2018-01-13       Impact factor: 4.813
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.